Glukil P 1mg/500mg/15mg Tablet SR
Marketer
Volks Biotech
Salt Composition
Glimepiride (1mg) + Metformin (500mg) + Pioglitazone (15mg)
Overview Glukil P 1mg/500mg/15mg Tablet SR
Diabetac Control SR tablets (1mg/500mg/15mg) combine ingredients to manage blood glucose. This medication, used alongside diet and exercise, improves glycemic control in adults with type 2 diabetes. It enhances insulin effectiveness, reducing blood sugar. Follow your physician's prescribed dosage and frequency for Diabetac Control SR tablets, taking them with food to prevent digestive discomfort. If a dose is missed, take it promptly unless the next dose is imminent; skip the missed dose then. Never double the dose. Excessive intake can cause dangerously low blood sugar (hypoglycemia). Concomitant use with other diabetes medications, alcohol, or missed meals increases hypoglycemia risk; regular blood sugar monitoring is crucial. Common side effects include nausea, diarrhea, abdominal pain, headache, bone fractures, and respiratory infections. Disclose kidney, liver, or heart conditions to your doctor before starting treatment. Pregnant or lactating individuals should consult their doctor. Kidney function tests will be performed prior to commencing treatment. Limit alcohol consumption while using this medication to minimize potential side effects.
Primary Ingredients of Glukil P 1mg/500mg/15mg Tablet SR
No text provided to rephrase.
Uses of Glukil P 1mg/500mg/15mg Tablet SR
Managing type 2 diabetes
Major Benefits of Glukil P 1mg/500mg/15mg Tablet SR:
Follow your doctor's instructions precisely regarding the dosage and treatment length for this medication. Ingest the Glukil P 1mg/500mg/15mg Tablet SR whole; do not crush, chew, or divide it. Administer this medication with a meal.
Common Side effects of Glukil P 1mg/500mg/15mg Tablet SR:
- Hypoglycemia (low blood glucose level)
- Headache
- Nausea
- Diarrhea
- Dizziness
- Vomiting
- Anemia (low number of red blood cells)
- Weakness
- Sinus infection
How to use Glukil P 1mg/500mg/15mg Tablet SR:
Administer this medication precisely as directed by your physician, adhering to the prescribed dosage and treatment schedule. Ingest the Glukil P 1mg/500mg/15mg Tablet SR whole; avoid chewing, crushing, or fracturing. Consume with food.
How Glukil P 1mg/500mg/15mg Tablet SR works:
Glukil P 1mg/500mg/15mg Extended-Release Tablets combine glimepiride, metformin, and pioglitazone—three distinct antidiabetic agents. These medications act via separate pathways to optimize blood glucose management when monotherapy or dual therapy proves insufficient. Glimepiride, a sulfonylurea, stimulates pancreatic insulin secretion, thereby reducing blood glucose levels. Metformin, a biguanide, reduces hepatic glucose production, slows intestinal glucose absorption, and enhances insulin responsiveness. Finally, pioglitazone, a thiazolidinedione, further improves insulin sensitivity.
SAFETY ADVICE
AlcoholUNSAFE
Combining Glukil P 1mg/500mg/15mg SR tablets with alcohol is not advisable.
PregnancyCONSULT YOUR DOCTOR
The extended-release Glukil P 1mg/500mg/15mg tablet may pose risks during pregnancy. While human data is scarce, animal research indicates potential harm to a fetus. A physician will assess the potential advantages against any risks prior to prescribing. Seek medical advice.
Breast feedingCONSULT YOUR DOCTOR
Prolonged-release Glukil P tablets (1mg/500mg/15mg) are likely unsafe for breastfeeding mothers. Available human data indicates potential transfer to breast milk, posing a risk to the infant.
DrivingCAUTION
Driving ability can be impaired by both hypoglycemia and hyperglycemia. Refrain from driving if you experience these conditions.
KidneyCAUTION
Patients with kidney impairment should use Glukil P 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician for guidance. This medication is contraindicated in patients with severe kidney disease. Regular kidney function monitoring is recommended during treatment.
LiverCAUTION
Patients with liver impairment should use Glukil P 1mg/500mg/15mg SR tablets cautiously, potentially requiring dosage modification. Consult a physician. Glukil P 1mg/500mg/15mg SR tablets are contraindicated in individuals with severe hepatic dysfunction.
What if you forget to take Glukil P 1mg/500mg/15mg Tablet SR :
Should you forget a Glukil P 1mg/500mg/15mg SR Tablet dose, administer it promptly. Nevertheless, if your next scheduled dose is imminent, omit the missed dose and resume your usual dosing regimen. Avoid taking a double dose.
Facts to Know About Glukil P 1mg/500mg/15mg Tablet SR
| Label | Value |
|---|---|
| Developing Habits | No. |
| Treatment Category | Diabetes Management |
3,018 People bought this recently